Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study

Conclusion: Drotaverine was significantly superior in efficacy as compared to Mebeverine in alleviating pain severity (starting from day 3), frequency and stools-elated symptoms of IBS.

Source: The Saudi Journal of Gastroenterology - June 25, 2021 Category: Gastroenterology Authors: Ramesh R Rai Sandeep Nijhawan Source Type: research